Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis

[Image: see text] There is a critical unmet need for therapeutics to treat the epidemic of comorbidities associated with obesity and type 2 diabetes, ideally devoid of nausea/emesis. This study developed monomeric peptide agonists of glucagon-like peptide 1 receptor (GLP-1R) and neuropeptide Y2 rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Milliken, Brandon T., Elfers, Clinton, Chepurny, Oleg G., Chichura, Kylie S., Sweet, Ian R., Borner, Tito, Hayes, Matthew R., De Jonghe, Bart C., Holz, George G., Roth, Christian L., Doyle, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956155/
https://www.ncbi.nlm.nih.gov/pubmed/33449689
http://dx.doi.org/10.1021/acs.jmedchem.0c01783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956155/
https://www.ncbi.nlm.nih.gov/pubmed/33449689
http://dx.doi.org/10.1021/acs.jmedchem.0c01783

Ejemplares similares